Comparative genetic architectures of schizophrenia in East Asian and European populations.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
12 2019
Historique:
received: 09 01 2019
accepted: 10 09 2019
pubmed: 20 11 2019
medline: 18 1 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

Schizophrenia is a debilitating psychiatric disorder with approximately 1% lifetime risk globally. Large-scale schizophrenia genetic studies have reported primarily on European ancestry samples, potentially missing important biological insights. Here, we report the largest study to date of East Asian participants (22,778 schizophrenia cases and 35,362 controls), identifying 21 genome-wide-significant associations in 19 genetic loci. Common genetic variants that confer risk for schizophrenia have highly similar effects between East Asian and European ancestries (genetic correlation = 0.98 ± 0.03), indicating that the genetic basis of schizophrenia and its biology are broadly shared across populations. A fixed-effect meta-analysis including individuals from East Asian and European ancestries identified 208 significant associations in 176 genetic loci (53 novel). Trans-ancestry fine-mapping reduced the sets of candidate causal variants in 44 loci. Polygenic risk scores had reduced performance when transferred across ancestries, highlighting the importance of including sufficient samples of major ancestral groups to ensure their generalizability across populations.

Identifiants

pubmed: 31740837
doi: 10.1038/s41588-019-0512-x
pii: 10.1038/s41588-019-0512-x
pmc: PMC6885121
mid: NIHMS1539625
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1670-1678

Subventions

Organisme : NHGRI NIH HHS
ID : U54 HG003067
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK114379
Pays : United States
Organisme : Medical Research Council
ID : MR/P005748/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : U01 MH109536
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH109514
Pays : United States
Organisme : NIMH NIH HHS
ID : K99 MH117229
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH109532
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH109539
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI139012
Pays : United States
Organisme : Medical Research Council
ID : G0800509
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : U01 MH109528
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085560
Pays : United States
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH085521
Pays : United States

Références

Stilo, S. A. & Murray, R. M. The epidemiology of schizophrenia: replacing dogma with knowledge. Dialogues Clin. Neurosci. 12, 305–315 (2010).
pubmed: 20954427 pmcid: 3181982
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
pmcid: 4112379
Pardiñas, A. F. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381–389 (2018).
pubmed: 29483656 pmcid: 5918692
Visscher, P. M. et al. 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5–22 (2017).
pubmed: 28686856 pmcid: 5501872
Li, Y. R. & Keating, B. J. Trans-ethnic genome-wide association studies: advantages and challenges of mapping in diverse populations. Genome Med. 6, 91 (2014).
pubmed: 25473427 pmcid: 4254423
Popejoy, A. B. & Fullerton, S. M. Genomics is failing on diversity. Nature 538, 161–164 (2016).
pubmed: 27734877 pmcid: 5089703
Yu, H. et al. Common variants on 2p16.1, 6p22.1 and 10q24.32 are associated with schizophrenia in Han Chinese population. Mol. Psychiatry 22, 954–960 (2017).
pubmed: 27922604
Li, Z. et al. Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia. Nat. Genet. 49, 1576–1583 (2017).
pubmed: 28991256
Moltke, I. et al. A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 512, 190–193 (2014).
pubmed: 25043022
Tang, C. S. et al. Exome-wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese. Nat. Commun. 6, 10206 (2015).
pubmed: 26690388
Clarke, T.-K. et al. Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112 117). Mol. Psychiatry 22, 1376–1384 (2017).
pubmed: 28937693 pmcid: 5622124
CONVERGE consortium. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 523, 588–591 (2015).
pmcid: 4522619
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet. 50, 668–681 (2018).
pubmed: 29700475 pmcid: 5934326
Report of the International Pilot Study of Schizophrenia (World Health Organization, 1973).
Carpenter, W. T. Jr, Strauss, J. S. & Bartko, J. J. Flexible system for the diagnosis of schizophrenia: report from the WHO International Pilot Study of Schizophrenia. Science 182, 1275–1278 (1973).
pubmed: 4752222
Jablensky, A. et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol. Med. Monogr. Suppl. 20, 1–97 (1992).
pubmed: 1565705
McGrath, J. J. Variations in the incidence of schizophrenia: data versus dogma. Schizophr. Bull. 32, 195–197 (2006).
pubmed: 16135560 pmcid: 2632174
Haro, J. M. et al. Cross-national clinical and functional remission rates: worldwide schizophrenia outpatient health outcomes (W-SOHO) study. Br. J. Psychiatry 199, 194–201 (2011).
pubmed: 21881098
Gureje, O. & Cohen, A. Differential outcome of schizophrenia: where we are and where we would like to be. Br. J. Psychiatry 199, 173–175 (2011).
pubmed: 21881093
Scutari, M., Mackay, I. & Balding, D. Using genetic distance to infer the accuracy of genomic prediction. PLoS Genet. 12, e1006288 (2016).
pubmed: 27589268 pmcid: 5010218
Martin, A. R. et al. Human demographic history impacts genetic risk prediction across diverse populations. Am. J. Hum. Genet. 100, 635–649 (2017).
pubmed: 28366442 pmcid: 5384097
Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584–591 (2019).
pubmed: 30926966 pmcid: 6563838
Bulik-Sullivan, B. et al. LD score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769
Geisler, S., Schöpf, C. L. & Obermair, G. J. Emerging evidence for specific neuronal functions of auxiliary calcium channel α
pubmed: 25504062
Heyes, S. et al. Genetic disruption of voltage-gated calcium channels in psychiatric and neurological disorders. Prog. Neurobiol. 134, 36–54 (2015).
pubmed: 26386135 pmcid: 4658333
Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381, 1371–1379 (2013).
pmcid: 3714010
Gulsuner, S. et al. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell 154, 518–529 (2013).
pubmed: 23911319 pmcid: 3894107
Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015).
pubmed: 26192919 pmcid: 4881818
Brown, B. C., Asian Genetic Epidemiology Network Type 2 Diabetes Consortium, Ye, C. J., Price, A. L. & Zaitlen, N. Transethnic genetic-correlation estimates from summary statistics. Am. J. Hum. Genet. 99, 76–88 (2016).
pubmed: 27321947 pmcid: 5005434
Okbay, A. et al. Genome-wide association study identifies 74 loci associated with educational attainment. Nature 533, 539–542 (2016).
pubmed: 27225129 pmcid: 4883595
Davies, G. et al. Genome-wide association study of cognitive functions and educational attainment in UK Biobank (N=112 151). Mol. Psychiatry 21, 758–767 (2016).
pubmed: 27046643 pmcid: 4879186
Cross-Disorder Group of the Psychiatric Genomics Consortium et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45, 984–994 (2013).
pmcid: 3800159
Anttila, V. et al. Analysis of shared heritability in common disorders of the brain. Science 360, eaap8757 (2018).
pubmed: 29930110
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
pubmed: 26414678 pmcid: 4626285
Bryois, J. et al. Evaluation of chromatin accessibility in prefrontal cortex of individuals with schizophrenia. Nat. Commun. 9, 3121 (2018).
pubmed: 30087329 pmcid: 6081462
Lindblad-Toh, K. et al. A high-resolution map of human evolutionary constraint using 29 mammals. Nature 478, 476–482 (2011).
pubmed: 21993624 pmcid: 3207357
De Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657
Genovese, G. et al. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat. Neurosci. 19, 1433–1441 (2016).
pubmed: 27694994 pmcid: 5104192
Bowden, J. & Dudbridge, F. Unbiased estimation of odds ratios: combining genomewide association scans with replication studies. Genet. Epidemiol. 33, 406–418 (2009).
pubmed: 19140132 pmcid: 2726957
Borenstein, M., Hedges, L. V., Higgins, J. P. T. & Rothstein, H. R. Introduction to Meta-Analysis (John Wiley & Sons, 2009).
Spain, S. L. & Barrett, J. C. Strategies for fine-mapping complex traits. Hum. Mol. Genet. 24, R111–R119 (2015).
pubmed: 26157023 pmcid: 4572002
Schaid, D. J., Chen, W. & Larson, N. B. From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat. Rev. Genet. 19, 491–504 (2018).
pubmed: 29844615 pmcid: 6050137
Huang, H. et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547, 173–178 (2017).
pubmed: 28658209 pmcid: 5511510
Farh, K. K.-H. et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337–343 (2015).
pubmed: 25363779
Swaminathan, B. et al. Fine mapping and functional analysis of the multiple sclerosis risk gene CD6. PLoS ONE 8, e62376 (2013).
pubmed: 23638056 pmcid: 3634811
Gaulton, K. J. et al. Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat. Genet. 47, 1415–1425 (2015).
pubmed: 26551672 pmcid: 4666734
Kichaev, G. & Pasaniuc, B. Leveraging functional-annotation data in trans-ethnic fine-mapping studies. Am. J. Hum. Genet. 97, 260–271 (2015).
pubmed: 26189819 pmcid: 4573268
Pawitan, Y., Seng, K. C. & Magnusson, P. K. E. How many genetic variants remain to be discovered? PLoS ONE 4, e7969 (2009).
pubmed: 19956539 pmcid: 2780697
Márquez-Luna, C., Loh, P.-R., South Asian Type 2 Diabetes (SAT2D) Consortium, SIGMA Type 2 Diabetes Consortium & Price, A. L. Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet. Epidemiol. 41, 811–823 (2017).
pubmed: 29110330 pmcid: 5726434
Chen, C.-Y., Han, J., Hunter, D. J., Kraft, P. & Price, A. L. Explicit modeling of ancestry improves polygenic risk scores and BLUP prediction. Genet. Epidemiol. 39, 427–438 (2015).
pubmed: 25995153 pmcid: 4734143
Yue, W.-H. et al. Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat. Genet. 43, 1228–1231 (2011).
pubmed: 22037552
Shi, Y. et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat. Genet. 43, 1224–1227 (2011).
pubmed: 22037555 pmcid: 3773910
Salinas, Y. D., Wang, L. & DeWan, A. T. Multiethnic genome-wide association study identifies ethnic-specific associations with body mass index in Hispanics and African Americans. BMC Genet. 17, 78 (2016).
pubmed: 27296613 pmcid: 4907283
International Schizophrenia Consortium et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).
pmcid: 3912837
Sekar, A. et al. Schizophrenia risk from complex variation of complement component 4. Nature 530, 177–183 (2016).
pubmed: 26814963 pmcid: 4752392
Chen, J. Y. et al. Effects of complement C4 gene copy number variations, size dichotomy, and C4A deficiency on genetic risk and clinical presentation of systemic lupus erythematosus in East Asian populations. Arthritis Rheumatol. 68, 1442–1453 (2016).
pubmed: 26814708 pmcid: 5114127
Hong, G. H. et al. Association of complement C4 and HLA-DR alleles with systemic lupus erythematosus in Koreans. J. Rheumatol. 21, 442–447 (1994).
pubmed: 7911834
Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet. 48, 1284–1287 (2016).
pubmed: 27571263 pmcid: 5157836
Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505–1513 (2018).
pubmed: 30297969 pmcid: 6287706
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn (American Psychiatric Association, 2000).
Nurnberger, J. I. Jr. et al. Diagnostic interview for genetic studies: rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 51, 849–859 (1994).
pubmed: 7944874
Sand, P. G. A lesson not learned: allele misassignment. Behav. Brain Funct. 3, 65 (2007).
pubmed: 18154681 pmcid: 2231368
Lam, M. et al. RICOPILI: Rapid Imputation for COnsortias PIpeLIne. Bioinformatics https://doi.org/10.1093/bioinformatics/btz633 (2019).
O’Connell, J. et al. A general approach for haplotype phasing across the full spectrum of relatedness. PLoS Genet. 10, e1004234 (2014).
pubmed: 24743097 pmcid: 3990520
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J. & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat. Genet. 44, 955–959 (2012).
pubmed: 22820512 pmcid: 3696580
1000 Genomes Project Consortium et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
pubmed: 17701901 pmcid: 1950838
Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).
pubmed: 16862161
Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010).
pubmed: 20616382 pmcid: 2922887
Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 43, 977–983 (2011).
Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 18, 497–511 (2013).
Boraska, V. et al. A genome-wide association study of anorexia nervosa. Mol. Psychiatry 19, 1085–1094 (2014).
pubmed: 24514567 pmcid: 4325090
Okbay, A. et al. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat. Genet. 48, 624–633 (2016).
pubmed: 27089181 pmcid: 4884152
Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet. 51, 63–75 (2019).
pubmed: 30478444
Sniekers, S. et al. Genome-wide association meta-analysis of 78,308 individuals identifies new loci and genes influencing human intelligence. Nat. Genet. 49, 1107–1112 (2017).
pubmed: 28530673 pmcid: 5665562
Juric, I., Aeschbacher, S. & Coop, G. The strength of selection against Neanderthal introgression. PLoS Genet. 12, e1006340 (2016).
pubmed: 27824859 pmcid: 5100956
Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740 (2011).
pubmed: 21546393 pmcid: 3106198
Turner, T. N. et al. denovo-db: a compendium of human de novo variants. Nucleic Acids Res. 45, D804–D811 (2017).
pubmed: 27907889
Pirooznia, M. et al. High-throughput sequencing of the synaptome in major depressive disorder. Mol. Psychiatry 21, 650–655 (2016).
pubmed: 26216301
Gautier, M. & Vitalis, R. rehh: an R package to detect footprints of selection in genome-wide SNP data from haplotype structure. Bioinformatics 28, 1176–1177 (2012).
pubmed: 22402612
Sabeti, P. C. et al. Genome-wide detection and characterization of positive selection in human populations. Nature 449, 913–918 (2007).
pubmed: 17943131 pmcid: 2687721
Weir, B. S. & Cockerham, C. C. Estimating F-statistics for the analysis of population structure. Evolution 38, 1358–1370 (1984).
pubmed: 28563791
Grossman, S. R. et al. A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 327, 883–886 (2010).
pubmed: 20056855
Grossman, S. R. et al. Identifying recent adaptations in large-scale genomic data. Cell 152, 703–713 (2013).
pubmed: 23415221 pmcid: 3674781
Ma, Y. et al. Properties of different selection signature statistics and a new strategy for combining them. Heredity 115, 426–436 (2015).
pubmed: 25990878 pmcid: 4611237
McVicker, G., Gordon, D., Davis, C. & Green, P. Widespread genomic signatures of natural selection in hominid evolution. PLoS Genet. 5, e1000471 (2009).
pubmed: 19424416 pmcid: 2669884
Gormley, P. et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat. Genet. 48, 856–866 (2016).
pubmed: 27322543 pmcid: 5331903
Wellcome Trust Case Control Consortium et al. Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet. 44, 1294–1301 (2012).
Lee, S. H., Goddard, M. E., Wray, N. R. & Visscher, P. M. A better coefficient of determination for genetic profile analysis. Genet. Epidemiol. 36, 214–224 (2012).
pubmed: 22714935

Auteurs

Max Lam (M)

Bio-X Institutes, Shanghai Jiao Tong University and Research Division, Institute of Mental Health Singapore, Singapore, Singapore.
Human Genetics, Genome Institute of Singapore, Singapore, Singapore.
Division of Psychiatry Research, the Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Research Division, Institute of Mental Health Singapore, Singapore, Singapore.

Chia-Yen Chen (CY)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.
Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Biogen, Cambridge, MA, USA.

Zhiqiang Li (Z)

Biomedical Sciences Institute of Qingdao University, Qingdao Branch of Shanghai Jiao Tong University Bio-X Institutes and the Affiliated Hospital of Qingdao University, Qingdao, China.
Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education) and the Collaborative Innovation Center for Brain Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.

Alicia R Martin (AR)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Julien Bryois (J)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Xixian Ma (X)

Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.

Helena Gaspar (H)

Social Genetic and Developmental Psychiatry, King's College London, London, UK.

Masashi Ikeda (M)

Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.

Beben Benyamin (B)

Australian Centre for Precision Health, School of Health Sciences, University of South Australia Cancer Research Institute, Adelaide, South Australia, Australia.
Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia.
South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.

Brielin C Brown (BC)

Data Science Institute, Columbia University, New York, NY, USA.
New York Genome Center, New York, NY, USA.

Ruize Liu (R)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Wei Zhou (W)

Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education) and the Collaborative Innovation Center for Brain Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Lili Guan (L)

Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
National Health Commission Key Laboratory of Mental Health (Peking University), Beijing, China.
National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.

Yoichiro Kamatani (Y)

Laboratory of Complex Trait Genomics, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan.
Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Sung-Wan Kim (SW)

Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea.

Michiaki Kubo (M)

RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.

Agung A A A Kusumawardhani (AAAA)

Department of Psychiatry, Cipto Mangunkusumo General Hospital, Universitas Indonesia, Jakarta, Indonesia.

Chih-Min Liu (CM)

Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
Department of Psychiatry, National Taiwan University College of Medicine, Taipei, Taiwan.

Hong Ma (H)

Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
National Health Commission Key Laboratory of Mental Health (Peking University), Beijing, China.
National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.

Sathish Periyasamy (S)

Queensland Brain Institute The University of Queensland, Brisbane, Queensland, Australia.
Queensland Center for Mental Health Research, The University of Queensland, Wacol, Queensland, Australia.

Atsushi Takahashi (A)

Laboratory for Statistical Analysis, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Department of Genomic Medicine, Research Institute, National Cerebral and Cardiovascular Center, Osaka, Japan.

Zhida Xu (Z)

Department of Psychiatry, University Medical Center Utrecht, Utrecht, the Netherlands.

Hao Yu (H)

Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
National Health Commission Key Laboratory of Mental Health (Peking University), Beijing, China.
National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.

Feng Zhu (F)

Center for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Psychiatry, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Wei J Chen (WJ)

Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
Department of Psychiatry, National Taiwan University College of Medicine, Taipei, Taiwan.
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

Stephen Faraone (S)

The State University of New York, Syracuse, NY, USA.

Stephen J Glatt (SJ)

Psychiatric Genetic Epidemiology and Neurobiology Laboratory (PsychGENe lab), Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA.

Lin He (L)

Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education) and the Collaborative Innovation Center for Brain Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.
Shanghai Center for Women and Children's Health, Shanghai, China.
Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, China.

Steven E Hyman (SE)

Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.

Hai-Gwo Hwu (HG)

Department of Psychiatry, National Taiwan University Hospital, Taipei, Taiwan.
Department of Psychiatry, National Taiwan University College of Medicine, Taipei, Taiwan.
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

Steven A McCarroll (SA)

Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Genetics, Harvard Medical School, Boston, MA, USA.

Benjamin M Neale (BM)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Pamela Sklar (P)

Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Dieter B Wildenauer (DB)

University of Western Australia, Perth, Western Australia, Australia.

Xin Yu (X)

Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
National Health Commission Key Laboratory of Mental Health (Peking University), Beijing, China.
National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.

Dai Zhang (D)

Peking University Sixth Hospital and Institute of Mental Health, Beijing, China.
National Health Commission Key Laboratory of Mental Health (Peking University), Beijing, China.
National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.

Bryan J Mowry (BJ)

Queensland Brain Institute The University of Queensland, Brisbane, Queensland, Australia.
Queensland Center for Mental Health Research, The University of Queensland, Wacol, Queensland, Australia.

Jimmy Lee (J)

Institute of Mental Health, Singapore, Singapore.

Peter Holmans (P)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine , Cardiff University, Cardiff, UK.

Shuhua Xu (S)

Key Laboratory of Computational Biology, CAS-MPG Partner Institute for Computational Biology, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, China.
School of Life Science and Technology, ShanghaiTech University, Shanghai, China.
Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming, China.
Collaborative Innovation Center of Genetics and Development, Shanghai, China.

Patrick F Sullivan (PF)

Department of Genetics, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Stephan Ripke (S)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Psychiatry and Psychotherapy Charité - Universitätsmedizin, Berlin, Germany.

Michael C O'Donovan (MC)

MRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine , Cardiff University, Cardiff, UK.

Mark J Daly (MJ)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.
Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.
Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland.

Shengying Qin (S)

Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education) and the Collaborative Innovation Center for Brain Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China.
Collaborative Innovation Center, Jining Medical University, Jining, China.

Pak Sham (P)

State Key Laboratory of Brain and Cognitive Sciences, Centre for Genomic Sciences, The University of Hong Kong, Hong Kong, China.
Department of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

Nakao Iwata (N)

Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Japan.

Kyung S Hong (KS)

Department of Psychiatry, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.

Sibylle G Schwab (SG)

Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, New South Wales, Australia.
Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia.

Weihua Yue (W)

Peking University Sixth Hospital and Institute of Mental Health, Beijing, China. dryue@bjmu.edu.cn.
National Health Commission Key Laboratory of Mental Health (Peking University), Beijing, China. dryue@bjmu.edu.cn.
National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China. dryue@bjmu.edu.cn.
IDG/McGovern Institute for Brain Research at Peking University, Beijing, China. dryue@bjmu.edu.cn.

Ming Tsuang (M)

Center for Behavioral Genomics, Department of Psychiatry, University of California, San Diego, San Diego, CA, USA. mtsuang@ucsd.edu.

Jianjun Liu (J)

Human Genetics, Genome Institute of Singapore, Singapore, Singapore. liuj3@gis.astar.edu.sg.
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. liuj3@gis.astar.edu.sg.

Xiancang Ma (X)

Department of Psychiatry, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. maxiancang@163.com.
Center for Brain Science, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. maxiancang@163.com.
Clinical Research Center for Mental Disease of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. maxiancang@163.com.

René S Kahn (RS)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. rene.kahn@mssm.edu.
Behavioral Health System, Icahn School of Medicine at Mount Sinai, New York, NY, USA. rene.kahn@mssm.edu.
Department of Psychiatry, Brain Center Rudolf Magnus, UMC Utrecht, Utrecht, the Netherlands. rene.kahn@mssm.edu.

Yongyong Shi (Y)

Bio-X Institutes, Shanghai Jiao Tong University and Research Division, Institute of Mental Health Singapore, Singapore, Singapore. shiyongyong@gmail.com.
Biomedical Sciences Institute of Qingdao University, Qingdao Branch of Shanghai Jiao Tong University Bio-X Institutes and the Affiliated Hospital of Qingdao University, Qingdao, China. shiyongyong@gmail.com.
Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education) and the Collaborative Innovation Center for Brain Science, Bio-X Institutes, Shanghai Jiao Tong University, Shanghai, China. shiyongyong@gmail.com.
Department of Psychiatry, First Teaching Hospital of Xinjiang Medical University, Ürümqi, China. shiyongyong@gmail.com.

Hailiang Huang (H)

Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA. hhuang@broadinstitute.org.
Stanley Center for Psychiatric Research, the Broad Institute of MIT and Harvard, Cambridge, MA, USA. hhuang@broadinstitute.org.
Department of Medicine, Harvard Medical School, Boston, MA, USA. hhuang@broadinstitute.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH